| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5614570 | Journal of Cardiology | 2017 | 5 Pages |
Abstract
In our cohort, 64% of the glucocorticoid-resistant or glucocorticoid-dependent patients maintained remission through a combined treatment with glucocorticoid, immunosuppressive agents, and/or biological agents. The combined use of immunosuppressive and biological agents appears to be a promising treatment option for achieving and maintaining remission in refractory TA patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hirokazu MD, PhD, Natsuko MD, Yusuke MD, PhD, Masayoshi MD, PhD, Yasuhiro MD, PhD, Takashi MD, PhD, Mitsuaki MD, PhD, FJCC,